About
4.79CAD-0.26 -5.15%
Closed • Updated at 16:51 GMT+00:00Market Cap$25.20M
Volume20.9K
Beta1.36
RSI41.35
Briacell Therapeutics Corp — investor relations, events, news, and company updates on 6ix.
Latest News
May 22 2026
BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026
May 15 2026
BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+(TM)
May 14 2026
BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+(TM) for Prostate Cancer
May 13 2026
BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
May 12 2026
BriaCell Phase 3 Bria-IMT(TM) Study Enrollment Surpasses 230 Patients
Community Chat
Ask AI
Try asking
Google Übersetzer